FB 04 - Universitätsmedizin
Johannes Gutenberg-Universität Mainz
- 06131/17-9704 oder 9799 (Sekretariat)
- 06131/17-9669
Herber, S; Otto, G; Schneider, J et al.
Transarterial chemoembolization (TACE) for inoperable intrahepatic cholangiocarcinoma.Cardiovasc Intervent Radiol. Bd. 30. H. 6. 2007 S. 1156-65
Otto, G; Heise, M; Moench, C et al.
Transarterial chemoembolization before liver transplantation in 60 patients with hepatocellular carcinomaTransplant Proc. Bd. 39. H. 2. 2007 S. 537-9
Herber, S; Pitton, M; Monch, C et al.
Transarterielle Chemoembolisation (TACE) des Hepatozellularen Karzinoms (HCC) bei Patienten mit Pfortaderthrombose - Erfahrungen.Zentralbl Chir. Bd. 132. H. 4. 2007 S. 306-15
Warger, T; Rechtsteiner, G; Schmid, B et al.
Transcutaneous Immunization With Imiquimod Is Amplified by CD40 Ligation and Results in Sustained Cytotoxic T-Lymphocyte Activation and Tumor Protection.Clin Rev Allergy Immunol. Bd. 32. H. 1. 2007 S. 57-66
Jones, J; Berkhoff, S; Weich, E et al.
Transient down-regulation of beta1 integrin subtypes on kidney carcinoma cells is induced by mechanical contact with endothelial cell membranesJ Cell Mol Med. Bd. 11. H. 4. 2007 S. 826-838
Bork, K; Frank, J; Grundt, B et al.
Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant).J Allergy Clin Immunol. Bd. 119. H. 6. 2007 S. 1497-503
Böcher, WO
Treatment of chronic hepatitis B - chances and limits of the new nucleos(t)ide analogues;Med Welt. Bd. 58. 2007 S. 1-7
Zafiropoulos, GG; Hoffmann, O; Kasaj, A et al.
Treatment of intrabony defects using guided tissue regeneration and autogenous spongiosa alone or combined with hydroxyapatite/beta-tricalcium phosphat bone substitute or bovine-derived xenograftJ Periodontol. Bd. 78. H. 11. 2007 S. 2216-2225
Helling, K; Schönfeld, U; Clarke, AH
Treatment of Meniére's disease by low-dosage intratympanic gentamicin application: effect on otolith functionLaryngoscope. Bd. 117. H. 12. 2007 S. 2244-2250
Sebastian, M; Passlick, B; Friccius-Quecke, H et al.
Treatment of non-small cell lung cancer patients with the trifunctional monoclonal antibody catumaxomab (anti-EpCAM x anti-CD3): a phase I study.Cancer Immunol Immunother. Bd. 56. H. 10. 2007 S. 1637-44